NIT
IMGN

NumerixS Investment Technologies’s Immunogen Inc IMGN Stock Holding History

NumerixS Investment Technologies’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-13,300
Closed -$45K – 1342
2020
Q1 		$45K Buy
+13,300
New +$58.1K 0.02% 632
2018
Q4 		– Sell
-25,500
Closed -$246K – 1453
2018
Q3 		$246K Buy
25,500
+6,700
+36% +$64.4K 0.05% 510
2018
Q2 		$187K Sell
18,800
-13,150
-41% -$139K 0.04% 540
2018
Q1 		$343K Sell
31,950
-8,661
-21% -$85.5K 0.08% 269
2017
Q4 		$260K Buy
+40,611
New +$250K 0.06% 388
2016
Q4 		– Sell
-67,400
Closed -$181K – 1372
2016
Q3 		$181K Sell
67,400
-19,700
-23% -$57.3K 0.02% 708
2016
Q2 		$268K Buy
+87,100
New +$546K 0.04% 609
2015
Q4 		– Sell
-15,400
Closed -$148K – 889
2015
Q3 		$148K Buy
+15,400
New +$225K 0.02% 611

Other funds holding IMGN

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

NumerixS Investment Technologies's IMGN Position: Q2 2020 in Review

NumerixS Investment Technologies sold out of Immunogen Inc (IMGN) in Q2 2020, closing a stake of 13,300 shares — an estimated $45K sold.

NumerixS Investment Technologies first reported a position in IMGN in Q3 2015 and held it in 8 quarters. The position peaked at $343K in Q1 2018. 189 funds tracked by Wall St. Rank hold IMGN as of Q2 2020.

  • NumerixS Investment Technologies reported no remaining Immunogen Inc position as of Q2 2020 after selling out during the quarter.
  • NumerixS Investment Technologies sold 13,300 Immunogen Inc shares in Q2 2020, an estimated $45K.
  • NumerixS Investment Technologies first reported a position in Immunogen Inc in Q3 2015 and held it in 8 quarters.
  • NumerixS Investment Technologies's Immunogen Inc position peaked at $343K in Q1 2018.
  • 189 funds tracked by Wall St. Rank held Immunogen Inc as of Q2 2020.

Based on NumerixS Investment Technologies's 13F filing for Q2 2020, filed 13 Aug 2020.